MGIM
KNSA icon

M&G Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

M&G Investment Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-142,527
Closed -$1.57M – 625
2021
Q3 		$1.57M Buy
+142,527
New +$1.86M ﹤0.01% 551

Other funds holding KNSA

PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

M&G Investment Management's KNSA Position: Q4 2021 in Review

M&G Investment Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q4 2021, closing a stake of 142,527 shares — an estimated $1.57M sold.

M&G Investment Management first reported a position in KNSA in Q3 2021 and held it in 1 quarter. The position peaked at $1.57M in Q3 2021. 103 funds tracked by Wall St. Rank hold KNSA as of Q4 2021.

  • M&G Investment Management reported no remaining Kiniksa Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 142,527 Kiniksa Pharmaceuticals shares in Q4 2021, an estimated $1.57M.
  • M&G Investment Management first reported a position in Kiniksa Pharmaceuticals in Q3 2021 and held it in 1 quarter.
  • M&G Investment Management's Kiniksa Pharmaceuticals position peaked at $1.57M in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.